1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Calming and Sleeping in Switzerland

Calming and Sleeping in Switzerland

  • April 2015
  • -
  • Euromonitor International
  • -
  • 27 pages

Insomnia is a sleep disorder characterised by difficulty in falling and/or staying asleep. Swiss medical research has shown that after 40 years of age, 20% of women and 15% of men consider their sleep as being poor or very poor and one out of two people complain about sleep disorders at least once in his/her life. This situation is caused by many factors, such as daily problems, job pressure and stress as well as other conditions such as sleep apnea and environmental factors like noise, light,...

Euromonitor International's Calming and Sleeping in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Calming and Sleeping market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Table Of Contents

Calming and Sleeping in Switzerland
CALMING AND SLEEPING IN SWITZERLAND
Euromonitor International
April 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Calming and Sleeping: Value 2009-2014
Table 2 Sales of Calming and Sleeping: % Value Growth 2009-2014
Table 3 NBO Company Shares of Calming and Sleeping: % Value 2010-2014
Table 4 LBN Brand Shares of Calming and Sleeping: % Value 2011-2014
Table 5 Forecast Sales of Calming and Sleeping: Value 2014-2019
Table 6 Forecast Sales of Calming and Sleeping: % Value Growth 2014-2019
Bayer (schweiz) AG in Consumer Health (switzerland)
Strategic Direction
Key Facts
Summary 1 Bayer (Schweiz) AG: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Bayer (Schweiz) AG: Competitive Position 2014
Novartis Consumer Health AG in Consumer Health (switzerland)
Strategic Direction
Key Facts
Summary 3 Novartis Consumer Health AG: Key Facts
Summary 4 Novartis Consumer Health AG: Operational Indicators (worldwide)
Company Background
Production
Summary 5 Novartis Consumer Health AG: Production Statistics 2014
Competitive Positioning
Summary 6 Novartis Consumer Health AG: Competitive Position 2014
Vifor Pharma AG in Consumer Health (switzerland)
Strategic Direction
Key Facts
Summary 7 Vifor Pharma AG: Key Facts
Summary 8 Vifor Pharma AG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Vifor Pharma AG: Competitive Position 2014
Executive Summary
Consumer Health Industry Feels Impact of Authorities' Efforts To Control Health Costs
Switzerland's OTC Liberalisation Continues To Arouse Passionate Debate
Multinationals Dominate the Landscape in Consumer Health
Chemists/pharmacies Remains the Top Channel Amidst Challenge From Internet Retailing
Limited Prospects Over the Forecast Period
Key Trends and Developments
Economic Indicators Show Positive Trends in Consumer Health
Health and Wellness Trend A Positive Boost To Demand of Consumer Health Products
Liberalising the Sale of OTC Medicines: A Priority To Reduce Healthcare Costs
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 8 Life Expectancy at Birth 2009-2014
Market Data
Table 9 Sales of Consumer Health by Category: Value 2009-2014
Table 10 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 11 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 12 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2009-2014
Table 14 Distribution of Consumer Health by Format: % Value 2009-2014
Table 15 Distribution of Consumer Health by Format and Category: % Value 2014
Table 16 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 10 OTC: Switches 2012-2014
Sources
Summary 11 Research Sources












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Receive information concerning the dynamics and forecasts in the OTC drugs and dietary supplements market - Receive information pertaining to the major regional trends in the global ...

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Global OTC Analgesics Market - Growth, Trends and Forecast (2017 - 2022)

Global OTC Analgesics Market - Growth, Trends and Forecast (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global OTC Analgesics market accounted for a market value of USD XX billion in 2015. The market is expected to reach USD XX billion in 2016 and USD XX billion by 2021, growing at a CAGR of xx% during ...

Otc Drugs Markets In China

January 2017 $ 4000

Otc Drugs Companies In China

January 2017 $ 1800

Download Unlimited Documents from Trusted Public Sources

OTC Markets in the US

  • March 2017
    10 pages
  • Pancreatic Canc...  

    Vitamin  

  • United States  

View report >

OTC Industry in the US

  • March 2017
    89 pages
  • OTC  

  • United States  

View report >

OTC Supply in the US

  • March 2017
  • Dietary Supplem...  

  • United States  

View report >

Otc Markets In Europe

21 days ago

Otc Industry In China

22 days ago

Related Market Segments :

OTC

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.